|
1
|
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.
|
Lancet
|
2007
|
3.36
|
|
2
|
The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting.
|
Hum Reprod
|
2011
|
3.07
|
|
3
|
Why do couples drop-out from IVF treatment? A prospective cohort study.
|
Hum Reprod
|
2008
|
2.32
|
|
4
|
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
|
J Clin Endocrinol Metab
|
2003
|
2.26
|
|
5
|
Symposium: Update on prediction and management of OHSS. A modern classification of OHSS.
|
Reprod Biomed Online
|
2009
|
2.20
|
|
6
|
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial.
|
Hum Reprod
|
2007
|
2.11
|
|
7
|
Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
|
Am J Obstet Gynecol
|
2015
|
2.08
|
|
8
|
Clomiphene and letrozole for reducing FSH consumption during ovarian stimulation: systematic review and meta-analysis.
|
Ultrasound Obstet Gynecol
|
2017
|
1.37
|
|
9
|
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
|
Hum Reprod Update
|
2008
|
1.26
|
|
10
|
The ISMAAR proposal on terminology for ovarian stimulation for IVF.
|
Hum Reprod
|
2007
|
1.15
|
|
11
|
Development, pharmacology and clinical experience with clomiphene citrate.
|
Hum Reprod Update
|
1997
|
0.99
|
|
12
|
Affordable ART: a different perspective.
|
Hum Reprod
|
2011
|
0.86
|
|
13
|
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis.
|
Hum Reprod Update
|
2010
|
0.86
|
|
14
|
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
|
Fertil Steril
|
2017
|
0.75
|
|
15
|
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
|
Cochrane Database Syst Rev
|
2017
|
0.75
|
|
16
|
The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators.
|
Reprod Biomed Online
|
2017
|
0.75
|
|
17
|
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
|
Hum Reprod
|
2017
|
0.75
|
|
18
|
The International Glossary on Infertility and Fertility Care, 2017.
|
Fertil Steril
|
2017
|
0.75
|
|
19
|
Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis.
|
Gynecol Obstet Invest
|
2013
|
0.75
|
|
20
|
Can we modify assisted reproductive technology practice to broaden reproductive care access?
|
Fertil Steril
|
2016
|
0.75
|